First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Conditions:   Mesothelioma, Malignant;   Mesothelioma, Malignant Pleural;   Mesothelioma Malignant Advanced Intervention:   Drug: Sintilimab+Anlotinib+Pemetrexed+Cisplatin Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials